Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
about
Chocolate, Air Pollution and Children's Neuroprotection: What Cognition Tools should be at Hand to Evaluate Interventions?A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomographyFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsMetabolomics of human brain aging and age-related neurodegenerative diseasesThe future of human cerebral cartography: a novel approachSelf-reported head injury and risk of late-life impairment and AD pathology in an AD center cohortThe application of retinal fundus camera imaging in dementia: A systematic review.A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings.Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's DiseaseAre Markov and semi-Markov models flexible enough for cognitive panel data?Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set.Mild to moderate Alzheimer dementia with insufficient neuropathological changes.Associations between hippocampal morphometry and neuropathologic markers of Alzheimer's disease using 7 T MRI.Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlatesLongitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.The neurobiological basis of cognitive impairment in Parkinson's disease.Improving dementia care: the role of screening and detection of cognitive impairment.Applicability of digital analysis and imaging technology in neuropathology assessment.Immune and myodegenerative pathomechanisms in inclusion body myositisNeurodegenerative disease: MRI biomarkers - a precision medicine tool in neurology?Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's diseasePositive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions.Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid.Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort.Seven challenges for neuroscienceAndrogen Deprivation Therapy and Future Alzheimer's Disease RiskInvestigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease.Clinical-pathological agreement in dementing disorders: embracing the complexitySensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.Comparison of two methods for the analysis of CSF Aβ and tau in the diagnosis of Alzheimer's diseaseCharacteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database.Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionRelationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation ProtocolPET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.Imaging biomarkers associated with cognitive decline: a review.Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's diseaseUse of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation.
P2860
Q26738827-B2DBFEAC-4B8D-43CB-A706-FD5A7D535432Q26744916-A55F1EDE-BFFD-4A56-9F26-16A116466BF9Q26784569-33C87B0A-BA33-4D52-B5EE-4F7D8D97D8F4Q26992344-1392F2CB-D699-4F9E-8D8F-31010F605E7EQ28085255-F685D83E-1B09-4EFB-9062-EA3A7335A47DQ28387899-087458EF-627D-44F3-ACFD-C543EC848E75Q30235603-78DFD0FF-478F-4A42-9D83-FE170D0AA646Q30382854-7A5E2452-F48B-44E7-BDFD-1F4B1C56DD64Q30659251-239092CC-5659-44C5-B665-884D128EB803Q30694251-438E4001-B15D-4974-91CD-C5B23AD39E48Q31047629-2A69AE25-C33F-4896-97EB-7E0D874B6CC9Q31140102-70EA97F2-DDBD-43EF-9C09-F256D48B1AF6Q33592693-E6D982FA-8820-423C-B7AE-A89CC460492AQ33623751-A416D443-7EC2-43D5-9267-36FF1C0CEDB6Q33683377-053CF0F4-4C1A-4D7E-927B-9E548E380B21Q33687554-43D0C0A9-892F-4638-AC7A-06C5D16BD6E7Q33708963-40B7BBBD-CB9A-4D6C-933C-01D63A783BA5Q33714693-CC70FA50-1C08-477E-8858-49CE42532FF5Q33724698-C05806F1-9745-401D-BE9B-435853D2DAB9Q33726875-E76C2BFD-38C3-4B98-A11A-51DB442D05D7Q33750657-7E4CDB8A-7851-49F9-AE83-04892EDB7502Q33753870-3A95EB92-4301-4FF4-B475-889925EDC93AQ33907524-994EDFB5-B3A0-4B06-BAF7-E4C51D374036Q34076179-BAA3C0F4-7FB9-49BF-848F-E67A918C3FCFQ34207044-01160855-0090-461E-8D36-4D6576478838Q34214255-6C6E6E48-0227-412A-8290-838B9538E27CQ34337167-E710DE4C-BB43-4067-B15A-380F4A05E6D6Q34378681-955BE515-D930-41AA-9B7B-35DA83645AF3Q34504328-9DE74C78-7F03-4C05-8BD9-16D53EF15EC2Q34538196-D58D4AC1-9ACA-4BC7-B4AF-E755A4D4990CQ34577618-959D037E-01E9-4EB4-9ABD-7C7B37393CE1Q34728483-4F57C2E2-565D-454B-A6B6-E044F6D80638Q34987497-890B98A3-63E9-4271-8343-967A0280FB65Q35071880-0FA213F4-4768-4B52-9DF3-810C9FCE2778Q35106472-7F866FBD-75E2-4238-8D94-4C96CF080546Q35143328-A2FF1D1A-4DE1-4A0D-827A-17D69777923AQ35158227-0BECDAA6-9658-4AE4-9C21-01D7CD29C8ECQ35185786-2841CE81-2695-4EC3-BD9D-7EE24F3DDC51Q35284971-6079AA69-FA56-47F8-A48E-E956DF67920EQ35576440-63944EE7-C3B8-4011-9D5C-85DEC79FE202
P2860
Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@ast
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@en
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@nl
type
label
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@ast
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@en
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@nl
prefLabel
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@ast
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@en
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@nl
P2860
P1476
Accuracy of the clinical diagn ...... er Disease Centers, 2005-2010.
@en
P2093
Leslie E Phillips
Sarah E Monsell
P2860
P304
P356
10.1097/NEN.0B013E31824B211B
P577
2012-04-01T00:00:00Z